SCHEMBL6895512

SCHEMBL6895512

CO[C@@H]1O[C@H](COCc2ccc(Cl)cc2)[C@](O)(Cc2ccccc2)[C@@](O)(Cc2ccccc2)[C@H]1O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PTPN2 P17706 1/20 0.33
PTPN1 P18031 1/20 0.33
NR1I2 O75469 1/20 0.32
PGR P06401 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
OPRK1 P41145 1/20 0.32
SLC6A2 P23975 1/20 0.32
SSTR1 P30872 1/20 0.32
SSTR2 P30874 1/20 0.32
SSTR4 P31391 1/20 0.32
SSTR3 P32745 1/20 0.32
SSTR5 P35346 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
LGALS8 O00214 1/20 0.32
CHRM3 P20309 2/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6895515 1.00 NPC1 (0.33) NPC1RAB9ASMN1; SMN2L3MBTL1PTPN2
SCHEMBL28102397 0.78 TSHR (0.41) SLC6A2TAAR1
SCHEMBL7565489 0.77 PPARG (0.33) HTT
SCHEMBL8928687 0.74 BCHE (0.39) PTPN2PTPN1SLC6A2SSTR1SSTR2
SCHEMBL8929742 0.74 BCHE (0.39) PTPN2PTPN1SLC6A2SSTR1SSTR2
SCHEMBL8928883 0.74 BCHE (0.39) PTPN2PTPN1SLC6A2SSTR1SSTR2
SCHEMBL7569063 0.73 PPARG (0.35)
SCHEMBL6886060 0.71 SSTR5 (0.53) PTPN2PTPN1SSTR1SSTR2SSTR4
SCHEMBL27737593 0.71 TAAR1 (0.40) SMN1; SMN2TAAR1HTT
SCHEMBL6886063 0.68 SSTR1 (0.60) PTPN2PTPN1SSTR1SSTR2SSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6693178-B2 HALOGENATED BENZYL ETHER GALACTOPYRANOSIDE, GLUCOPYRANOSIDE, RIBOFURANOSIDE OR XYLOFURANOSIDE DERIVATIVES; STABLE, EASILY REMOVED MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2004-02-17 US disclosed
US-20030181690-A1 Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030181690-A1 Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries FUT5, FUT6, UGCG NPC1 1892/4885RAB9A 3053/4885SMN1; SMN2 4131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.